Bristol Myers’s stock pops as earnings top estimates and company raises guidance
Read more at MarketWatch
-
Biogen’s stock hit by soft sales of Alzheimer’s treatment
Business - MarketWatch - October 30 -
Pfizer’s earnings crush estimates as company raises guidance
Business - MarketWatch - October 29 -
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
Business - CNBC - October 31 -
Merck’s stock slides as Q3 earnings beat estimates, but company lowers guidance
Business - MarketWatch - October 31 -
Freshpet’s stock jumps premarket after earnings beat and company raises guidance
Business - MarketWatch - November 4 -
Lowe’s CEO confident in retailer’s ability to manage Trump tariffs after earnings beat
Business - MarketWatch - Yesterday -
Centene’s stock soars 11% after earnings sweep past estimates and company backs guidance
Business - MarketWatch - October 25
More from MarketWatch
-
Analysts don’t budge on Williams-Sonoma ratings despite stock rally
Business - MarketWatch - 6 minutes ago -
Is higher inflation here to stay? Fed faces hurdles in quest to crush rising prices.
Business - MarketWatch - 15 minutes ago -
Treasury yields steady as traders weigh increased Russia-Ukraine tensions
Business - MarketWatch - 16 minutes ago -
Philadelphia Fed’s manufacturing gauge shows activity contracted in November
Business - MarketWatch - 22 minutes ago -
MicroStrategy’s stock could do something it hasn’t done in 24 years as bitcoin surges
Business - MarketWatch - 35 minutes ago